1. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
   Yaseen Hussain et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
2. Eupafolin regulates non-small-cell lung cancer cell proliferation, migration, and invasion by suppressing MMP9 and RhoA via FAK/PI3K/AKT signaling pathway
   Xiang Wang et al, 2023, Journal of Biosciences CrossRef
3. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance
   Teng Liu et al, 2022, Journal of Cancer Research and Therapeutics CrossRef
4. Rebaudioside B Attenuates Lung Ischemia-reperfusion Injury Associated Apoptosis and Inflammation
   Xiangyang Wu et al, 2024, Recent Advances in Inflammation & Allergy Drug Discovery CrossRef
5. Protective Role of Eupafolin against Tumor, Inflammation, Melanogenesis, Viral Disease and Renal Injury: Pharmacological and Analytical Aspects through Scientific Data Analysis
   Dinesh Kumar Patel, 2022, Current Chinese Science CrossRef
6. Anticonvulsive and Neuroprotective Effects of Eupafolin in Rats Are Associated with the Inhibition of Glutamate Overexcitation and Upregulation of the Wnt/β-Catenin Signaling Pathway
   Wei-Horng Jean et al, 2022, ACS Chemical Neuroscience CrossRef
7. A review on the impact of TRAIL on cancer signaling and targeting via phytochemicals for possible cancer therapy
   Balasubramani Govindasamy et al, 2023, International Journal of Biological Macromolecules CrossRef
8. Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms
   Essa M. Bajalia et al, 2022, Cancers CrossRef
9. Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
   Abdelhakim Bouyahya et al, 2022, Cancers CrossRef
10. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways
    Jiahui Wei et al, 2022, European Journal of Pharmacology CrossRef